Mirum Pharmaceuticals Inc.

09/21/2021 | Press release | Distributed by Public on 09/21/2021 06:12

Mirum Pharmaceuticals and Takeda Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan